Target intelligence / Profile preview

Varicella-zoster virus protein (null)

Target
null
Molecular classification
Other (Viral protein), Enzyme (individual proteins), Transcription factor (individual proteins), Receptor (envelope glycoproteins, e.g., fusion machinery), Structural protein (capsid, tegument, envelope components)
01

Overview

Varicella-zoster virus proteins comprise the diverse set of functional proteins encoded by the genome of **Varicella-zoster virus (VZV)**, a human-restricted **alphaherpesvirus** that is the causative agent of chickenpox (varicella) and shingles (herpes zoster)[4][6][2]. The viral proteome includes more than 70 proteins, functionally classified as **structural proteins** (capsid, envelope glycoproteins, tegument components), **enzymes** (such as DNA polymerase, kinases, nucleases, and the DNA helicase-primase complex), and **regulatory factors** like the major immediate-early protein 62 (IE62)[4][6][2]. Key viral glycoproteins (notably **gB, gH, and gL** among others) mediate fusion with host cells, enabling viral entry and spread[3][4][7][9]. Capsid proteins assemble into complex icosahedral structures critical for viral genome packaging and virion stability[1][4]. Immediate-early regulatory proteins direct transcription of viral genes and manipulate the host cell environment to support infection and immune evasion[4][2]. Some VZV proteins, such as the DNA polymerase, are the **primary molecular targets of antiviral drugs** (e.g., acyclovir, valacyclovir), while others (for example, components of the fusion complex or capsid) are being investigated as novel therapeutic targets[3][1][9]. Detection of VZV DNA or specific viral proteins is the molecular basis for diagnostic tests and may be used as **biomarkers** for infection or vaccine response. **Note:** "Varicella-zoster virus proteins" is a broad, collective category and does not refer to a single molecular target; structured information is best constructed for individual proteins (e.g., "Varicella-zoster virus glycoprotein B"). This entry is flagged as *is_incorrect* because it is not specific to a single molecular target as typically defined in drug discovery or pharmacology[1][2][3][4][9].

Other names
VZV proteinsVZV viral proteinsHuman herpesvirus 3 proteinsHHV-3 proteins
02

Mechanism of action

Inhibition of viral DNA polymerase, Inhibition of viral replication, Potential capsid assembly or fusion inhibition

03

Biological functions

Viral entry (glycoproteins)Viral replicationVirion assemblyImmune evasionTranscriptional regulation (immediate-early proteins)Membrane fusion
04

Disease associations

Infection (varicella/chickenpox, herpes zoster/shingles, CNS complications)
05

Safety considerations

Antiviral resistance (notably to acyclovir)cytotoxicityemergence of resistant strainscross-reactivity with host antigenschallenges delivering drugs to neuronal tissues (site of latency/reactivation)
06

Interacting drugs

Acyclovir

5 more in the full profile.

07

Biomarkers

VZV DNAanti-VZV IgG/IgMviral glycoproteins (gE, gB)immediate-early protein 62 (IE62)

Beyond the preview

Go deeper on Varicella-zoster virus protein (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Varicella-zoster virus protein (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call